Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis by Pavord, I, Lettis, S, Anzueto, A, Barnes, N

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids by Siddiqui, S, Pavord, I, Barnes, N, Guasconi, A, Lettis, S, Pascoe, S, Petruzzelli, S

Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease by Steven J. Pascoe, Alberto Papi, Dawn Midwinter, Sally Lettis, Neil Barnes

Get full text

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids by Siddiqui SH, Pavord ID, Barnes NC, Guasconi A, Lettis S, Pascoe S, Petruzzelli S

Get full text

Implementing evidence in practice: do action lists work? by Haley, M, Lettis, A, Rose, P, Jenkins, L, Glasziou, P, Rose, P

Predictors of pneumonia on routine chest radiographs in patients with COPD: a post hoc analysis of two 1-year randomized controlled trials by Rubin DB, Ahmad HA, O'Neal M, Bennett S, Lettis S, Galkin DV, Crim C

Get full text

Blood eosinophil levels as a biomarker in COPD by Brusselle, G, Pavord, I, Landis, S, Pascoe, S, Lettis, S, Morjaria, N, Barnes, N, Hilton, E

InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations by Dave Singh, Gerard J. Criner, Mark T. Dransfield, David M. G. Halpin, MeiLan K. Han, Peter Lange, Sally Lettis, David A. Lipson, David Mannino, Neil Martin, Fernando J. Martinez, Bruce E. Miller, Robert Wise, Chang-Qing Zhu, David Lomas

Get full text

Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis by MeiLan K. Han, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, Christine E. Jones, Sally Kilbride, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Robert A. Wise, Ian P. Naya, Dave Singh

Get full text